Sunitinib Sandoz 12.5 mg hard capsules Malta - English - Medicines Authority

sunitinib sandoz 12.5 mg hard capsules

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Sandoz 25 mg hard capsules Malta - English - Medicines Authority

sunitinib sandoz 25 mg hard capsules

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib Sandoz 50 mg hard capsules Malta - English - Medicines Authority

sunitinib sandoz 50 mg hard capsules

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Sunitinib Dr. Reddy’s 12.5 mg hard capsules Malta - English - Medicines Authority

sunitinib dr. reddy’s 12.5 mg hard capsules

reddy pharma iberia s.a. avinguda de josep tarradellas 38 barcelona, 08029, spain - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Dr. Reddy’s 25 mg hard capsules Malta - English - Medicines Authority

sunitinib dr. reddy’s 25 mg hard capsules

reddy pharma iberia s.a. avinguda de josep tarradellas 38 barcelona, 08029, spain - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib Dr. Reddy’s 50 mg hard capsules Malta - English - Medicines Authority

sunitinib dr. reddy’s 50 mg hard capsules

reddy pharma iberia s.a. avinguda de josep tarradellas 38 barcelona, 08029, spain - hard capsule - sunitinib 50 mg - antineoplastic agents

Sutent European Union - English - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastic agents - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance.metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults.pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults.experience with sutent as first-line treatment is limited (see section 5.1).

SUTENT CAPSULE Canada - English - Health Canada

sutent capsule

pfizer canada ulc - sunitinib (sunitinib malate) - capsule - 12.5mg - sunitinib (sunitinib malate) 12.5mg - antineoplastic agents

SUTENT CAPSULE Canada - English - Health Canada

sutent capsule

pfizer canada ulc - sunitinib (sunitinib malate) - capsule - 25mg - sunitinib (sunitinib malate) 25mg - antineoplastic agents

SUTENT CAPSULE Canada - English - Health Canada

sutent capsule

pfizer canada ulc - sunitinib (sunitinib malate) - capsule - 50mg - sunitinib (sunitinib malate) 50mg - antineoplastic agents